Submitted:
04 June 2025
Posted:
06 June 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| AH | Arterial hypertension |
| CS | Caesarеan section |
| BMI | Body mass index |
| GDM | Gestational diabetes mellitus |
| IUGR | Intrauterine growth restriction |
References
- Langley-Evans, S.C.; Pearce, J.; Ellis, S. Overweight, obesity and excessive weight gain in pregnancy as risk factors for adverse pregnancy outcomes: A narrative review. J Hum Nutr Diet. 2022, 35, 250–264. [Google Scholar] [CrossRef] [PubMed]
- Lubrano, C.; Locati, F.; Parisi, F.; Anelli, G.M.; Ossola, M.W.; Cetin, I. Gestational weight gain as a modifiable risk factor in women with extreme pregestational BMI. Nutrients 2025, 17, 736. [Google Scholar] [CrossRef] [PubMed]
- Tabacu, M.C.; Istrate-Ofiţeru, A.M.; Manolea, M.M.; Dijmărescu, A.L.; Rotaru, L.T.; Boldeanu, M.V.; Şerbănescu, M.S.; Tudor, A.; Novac, M.B. Maternal obesity and placental pathology in correlation with adverse pregnancy outcome. Rom J Morphol Embryol. 2022, 63, 99–104. [Google Scholar] [CrossRef] [PubMed]
- Paredes, C.; Hsu, R.C.; Tong, A.; Johnson, J.R. Obesity and pregnancy. Neoreviews 2021, 22, e78–e87. [Google Scholar] [CrossRef] [PubMed]
- Clemente-Suárez, V.J.; Beltrán-Velasco, A.I.; Redondo-Flórez, L.; Martín-Rodríguez, A.; Tornero-Aguilera, J.F. Global impacts of western diet and its effects on metabolism and health: A narrative review. Nutrients 15, 2749. [CrossRef] [PubMed]
- Poniedziałek-Czajkowska, E.; Mierzyński, R.; Leszczyńska-Gorzelak, B. Preeclampsia and obesity - the preventive role of exercise. Int J Environ Res Public Health. 2023, 20, 1267. [Google Scholar] [CrossRef] [PubMed]
- Uzunov, A.V.; Secara, D.C.; Mehedințu, C.; Cîrstoiu, M.M. Preeclampsia and neonatal outcomes in adolescent and adult patients. J Med Life 2022, 15, 1488–1492. [Google Scholar] [CrossRef] [PubMed]
- Jung, E.; Romero, R.; Yeo, L.; Gomez-Lopez, N.; Chaemsaithong, P.; Jaovisidha, A.; Gotsch, F.; Erez, O. The etiology of preeclampsia. Am J Obstet Gynecol. 2022, 226, S844–S866. [Google Scholar] [CrossRef] [PubMed]
- Lewandowska, M.; Więckowska, B.; Sajdak, S.; Lubiński, J. Pre-pregnancy obesity vs. other risk factors in probability models of preeclampsia and gestational hypertension. Nutrients 2020, 12, 2681. [Google Scholar] [CrossRef] [PubMed]
- Marshall, N.E.; Abrams, B.; Barbour, L.A.; Catalano, P.; Christian, P.; Friedman, J.E.; Hay, W.W. Jr.; Hernandez, T.L.; Krebs, N.F.; Oken, E.; Purnell, J.Q.; Roberts, J.M.; Soltani, H.; Wallace, J.; Thornburg, K.L. The importance of nutrition in pregnancy and lactation: lifelong consequences. Am J Obstet Gynecol. 2022, 226, 607–632. [Google Scholar] [CrossRef] [PubMed]
- Grenier, L.N.; Atkinson, S.A.; Mottola, M.F.; Wahoush, O.; Thabane, L.; Xie, F.; Vickers-Manzin, J.; Moore, C.; Hutton, E.K.; Murray-Davis, B. Be healthy in pregnancy: Exploring factors that impact pregnant women’s nutrition and exercise behaviours. Matern Child Nutr. 2021, 17, e13068. [Google Scholar] [CrossRef] [PubMed]
- Chang, K.J.; Seow, K.M.; Chen, K.H. Preeclampsia: Recent advances in predicting, preventing, and managing the maternal and fetal life-threatening condition. Int J Environ Res Public Health 2023, 20, 2994. [Google Scholar] [CrossRef] [PubMed]
- Martin-Alonso, R.; Prieto, P.; Fernández-Buhigas, I.; German-Fernandez, C.; Aramburu, C.; Piqueras, V.; Cuenca-Gomez, D.; Ferrer, E.; Rolle, V.; Santacruz, B.; et al. Association between perinatal outcomes and maternal risk factors: A cohort study. Medicina 2024, 60, 1071. [Google Scholar] [CrossRef] [PubMed]

| Characteristics | n (%) | Mean±SD (min-max) |
|---|---|---|
| Age | - | 29.33±6.387 (14-48) |
| Parity | ||
| This CS is first | 304 (54.80%) | - |
| This CS is second | 190 (45.20%) | - |
| Complications of the pregnancy | ||
| Moderate preeclampsia | 62 (12.55%) | - |
| Severe preeclampsia | 14 (2.83%) | - |
| GDM | 13 (2.63%) | - |
| IUGR | 10 (2.02%) | - |
| Abruptio (ablatio) placentae | 4 (0.80%) | - |
| Macrosomia foeti | 4 (0.80%) | - |
| Comorbidities | ||
| Arterial hypertension | 17 (3.44%) | - |
| Diabetes (pre-pregnancy) | 8 (1.62%) | - |
| Insulin resistance | 15 (3.07%) | - |
| Autoimmune thyroiditis | 29 (5.87%) | - |
| None registered | 295 (59.72%) | - |
| Anthropometric data | ||
| Height in cm | - | 164.12±6.176 (146-189) |
| Weight in kg | - | 81.51±16.969 (48-170) |
| Waist circumference in cm | - | 107.77±10.786 (76-147) |
| Weight gain during pregnancy in kg | - | 15.06±5.943 (1-40) |
| BMI by classes (according to WHO) and average weight gain values in kg | ||
| Normal weight 18.5-24.9 | 78 (15.79%) | 11.72±3.646 (3-25) |
| Overweight – 25.0-29.9 | 187 (37.85%) | 14.75±4.558 (1-26) |
| Obesity I degree 30.0-34.9 | 138 (27.94%) | 15.77±6.026 (4-30) |
| Obesity II degree 35.0-39.9 | 60 (12.14%) | 16.62±7.323 (5-36) |
| Obesity III degree - over 40.0 | 31 (6.28%) | 19.16±9.592 (3-40) |
| Degree of prematurity | n | % | Mean weight ± SD (min-max) |
|---|---|---|---|
| I-st degree of prematurity | 47 | 74.60 | 2299.36±150.454 (2000-2490) |
| II-nd degree of prematurity | 12 | 19.05 | 1720.00±138.367 (1530-1960) |
| III-rd degree of prematurity | 3 | 4.76 | 1323.33±280.060 (1000-1490) |
| IV-th degree of prematurity | 1 | 1.59 | 860 (one case) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).